Skip to main content
. Author manuscript; available in PMC: 2013 Feb 1.
Published in final edited form as: Am J Gastroenterol. 2012 Nov 13;108(1):40–47. doi: 10.1038/ajg.2012.363

Figure 1.

Figure 1

Forrest plot of meta-analysis of “loss or response” according to patients’ antibodies to infliximab (ATI) status (ATI+ or ATI−).